STRENSIQ
These highlights do not include all the information needed to use STRENSIQ safely and effectively. See full prescribing information for STRENSIQ. STRENSIQ (asfotase alfa) injection, for subcutaneous use Initial U.S. Approval: 2015
3387574f-5eaa-4501-a71d-4cbfbd563031
HUMAN PRESCRIPTION DRUG LABEL
Mar 14, 2023
Alexion Pharmaceuticals, Inc.
DUNS: 789359510
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ASFOTASE ALFA
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
ASFOTASE ALFA
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
ASFOTASE ALFA
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
ASFOTASE ALFA
Product Details
FDA regulatory identification and product classification information